| Literature DB >> 31198691 |
Afra Hassan Elrashid1, Basmah Sulaiman Alshaiji2, Sara Abdulwahab Saleh2, Khadijah Ahmed Zada2, Mohammad Abdul Baseer3.
Abstract
OBJECTIVES: Resin infiltration is a minimally invasive technique for treating noncavitated proximal caries. It slows/stops the carious lesion progression rate by creating a diffusion barrier inside the porous enamel lesion body. The aim was to evaluate the efficacy of resin infiltration on noncavitated proximal carious lesions in primary and permanent teeth.Entities:
Keywords: Efficacy; permanent teeth; primary teeth; proximal carious lesions; resin infiltration
Year: 2019 PMID: 31198691 PMCID: PMC6559044 DOI: 10.4103/jispcd.JISPCD_26_19
Source DB: PubMed Journal: J Int Soc Prev Community Dent ISSN: 2231-0762
Literature search strategies
| Electronic source | Search strategy |
|---|---|
| EBSCOhost | Most reported terms: |
| PubMed | a. Resin infiltration OR caries infiltration AND proximal lesions OR proximal caries |
| Wiley Library | |
| Cochrane Library | b. Sealing AND resin infiltration OR caries infiltration AND proximal lesions OR proximal caries |
| Google Scholar | |
| OpenGrey | |
| OpenThesis | |
| PubMed | MeSH terms: ((((“Cariostatic agents/therapeutic use” [MAJR]) OR “Dental caries/prevention and control” [MAJR]) AND “Disease Progression” [MeSH terms]) AND “Humans” [MeSH terms]) AND “Resins, synthetic/therapeutic use” [MAJR] |
MeSH=Medical Subject Headings
Figure 1Flow diagram showing study selection
Characteristics of studies included in the qualitative synthesis (systematic review)
| Authors and year of publication | Study design | Population (followed up participants) | Follow-up period | Intervention | Comparison | Outcome assessment method |
|---|---|---|---|---|---|---|
| Ammari | Split-mouth controlled randomized clinical trial | 42 children (42 lesion pairs) Age range of children at baseline: 5-8 years old | 6 and 12 months | Resin infiltration of NCPLs in primary molars Infiltrant: Icon®, (DMG, Hamburg, Germany) | Test group (fluoridated toothpaste + flossing + infiltration) Control group (fluoridated toothpaste + flossing) | Pairwise radiographic comparison of baseline and follow-up bitewing radiographs |
| Arthur | Double-blind split-mouth placebo-controlled randomized clinical trial | 17 participants (27 lesion pairs) Age range at baseline: 16-41 years old | 36 months | Resin infiltration of NCPLs Infiltrant: Icon® (DMG, Hamburg, Germany) | Placebo treatment | Pairwise radiographic comparison of baseline and follow-up bitewing radiographs |
| Ekstrand, Bakhshandeh and Martignon 2010 | Split-mouth controlled randomized clinical trial | 39 children | 6 months and 12 months | Resin infiltration of NCPLs Infiltrant resin: Triethylene glycol dimethacrylate- based resin, camphorquinone, additives; DMG, Hamburg, Germany | Test lesion: resin infiltration followed by FV Control lesion: Only FV | Scoring caries progression in bitewing radiographs |
| Foster Page | Split-mouth placebo-controlled randomized controlled trial | 69 children Age range at baseline: 7-9 years old | 6, 12, and 24 months | Resin infiltration of NCPLs Infiltrant: DMG Icon preproduct | Test group (infiltration: DMG Icon preproduct and FV) Control group (FV) | Pairwise radiographic comparison of baseline and follow-up bitewing radiographs |
| Martignon | Split-mouth controlled randomized clinical trial | 37 participants (each had at least 3 NCPLs) Age range at baseline: 16-35 years old | 36 months (annual follow-up) | Resin infiltration of NCPLs Infiltrant: ICON® preproduct (DMG, Hamburg, Germany) | Test- A (Infiltration: ICON-preproduct; DMG) Test-B (Sealing: Prime-Bond NT; Dentsply) Control-C (Placebo) | Pairwise radiographic comparison of baseline and follow-up bitewing radiographs |
| Meyer-Lueckel, Bitter and Paris 2012 | Split-mouth placebo-controlled randomized clinical trial | 19 young adults (25 lesion pairs) | 18 and 36 months | Resin infiltration of NCPLs Infiltrant: Icon, preproduct; DMG, Hamburg | Placebo treatment | Pairwise radiographic comparison and DSR of baseline and follow-up bitewing radiographs |
| Meyer-Lueckel | Split-mouth placebo-controlled randomized clinical trial | 79 participants (218 lesion pairs) Age range at baseline: 17-29 years old | 10 and 18 months | Resin infiltration of NCPLs Infiltrant: Icon; DMG, Hamburg, Germany | Placebo treatment | Pairwise radiographic comparison of baseline and follow-up bitewing radiographs |
NCPLs=Noncavitated proximal lesion/s, FV=Fluoride varnish, DSR=Digital subtraction radiography, DMG=Dental milestones guaranteed company
Figure 2Risk-of-bias assessment summary
Figure 3Forest plot of comparison: Proximal resin infiltration versus control/placebo, outcome: Caries progression rate in permanent teeth (pairwise, 18–36 months’ follow-up)
Figure 4Forest plot of comparison: Proximal resin infiltration versus control/placebo, outcome: Caries progression rate in primary teeth (pairwise, 12–24 months’ follow-up)
Quality of evidence by the GRADE approach
| Summary of findings: | ||||||
| Resin infiltration compared to Control/placebo for slowing/arresting caries progression rate | ||||||
| Patient or population: slowing/arresting caries progression rate Setting: Secondary care setting Intervention: Resin infiltration Comparison: Control/placebo | ||||||
| Caries progression rate in permanent teeth assessed with: Pairwise comparison follow up: range 18 months to 36 months | 301 per 1,000 | 57 per 1,000 | RR 0.19 | 478 (3 RCTs) | ⊕⊕⊕⊕HIGH | |
| Caries progression rate in primary teeth assessed with: Secondary care setting follow up: range 12 months to 24 months | 209 per 1,000 | RR 0.48 | 209 (2 RCTs) | ⊕⊕⊕⊕HIGH | ||
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; RR: Risk ratio. GRADE Working Group grades of evidence. High certainty: We are very confident that the true effect lies close to that of the estimate of the effect Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect. Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect